BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 26814968)

  • 1. An essential receptor for adeno-associated virus infection.
    Pillay S; Meyer NL; Puschnik AS; Davulcu O; Diep J; Ishikawa Y; Jae LT; Wosen JE; Nagamine CM; Chapman MS; Carette JE
    Nature; 2016 Feb; 530(7588):108-12. PubMed ID: 26814968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and cellular biology of adeno-associated virus attachment and entry.
    Zengel J; Carette JE
    Adv Virus Res; 2020; 106():39-84. PubMed ID: 32327148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATF6-Mediated Unfolded Protein Response Facilitates Adeno-associated Virus 2 (AAV2) Transduction by Releasing the Suppression of the AAV Receptor on Endoplasmic Reticulum Stress.
    Cui M; Zhao Q; Wang J; Si Y; Cheng S; Ding W
    J Virol; 2022 Feb; 96(3):e0110321. PubMed ID: 34851146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor.
    Dudek AM; Pillay S; Puschnik AS; Nagamine CM; Cheng F; Qiu J; Carette JE; Vandenberghe LH
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor.
    Pillay S; Zou W; Cheng F; Puschnik AS; Meyer NL; Ganaie SS; Deng X; Wosen JE; Davulcu O; Yan Z; Engelhardt JF; Brown KE; Chapman MS; Qiu J; Carette JE
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus 2 bound to its cellular receptor AAVR.
    Zhang R; Cao L; Cui M; Sun Z; Hu M; Zhang R; Stuart W; Zhao X; Yang Z; Li X; Sun Y; Li S; Ding W; Lou Z; Rao Z
    Nat Microbiol; 2019 Apr; 4(4):675-682. PubMed ID: 30742069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polarized AAVR expression determines infectivity by AAV gene therapy vectors.
    Hamilton BA; Li X; Pezzulo AA; Abou Alaiwa MH; Zabner J
    Gene Ther; 2019 Jun; 26(6):240-249. PubMed ID: 30962536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors.
    Silveria MA; Large EE; Zane GM; White TA; Chapman MS
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host determinants of adeno-associated viral vector entry.
    Pillay S; Carette JE
    Curr Opin Virol; 2017 Jun; 24():124-131. PubMed ID: 28672171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering a highly durable adeno-associated virus receptor for analytical applications.
    Yoshida K; Tsunekawa Y; Kurihara K; Watanabe K; Makino-Manabe Y; Wada M; Tanaka T; Ide T; Okada T
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101157. PubMed ID: 38152699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Species Permissivity: Structure of a Goat Adeno-Associated Virus and Its Complex with the Human Receptor AAVR.
    Large EE; Silveria MA; Weerakoon O; White TA; Chapman MS
    J Virol; 2022 Dec; 96(24):e0148422. PubMed ID: 36453885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR.
    Zhang R; Xu G; Cao L; Sun Z; He Y; Cui M; Sun Y; Li S; Li H; Qin L; Hu M; Yuan Z; Rao Z; Ding W; Rao Z; Lou Z
    Nat Commun; 2019 Aug; 10(1):3760. PubMed ID: 31434885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR Screen Identifies the Cell Polarity Determinant Crumbs 3 as an Adeno-associated Virus Restriction Factor in Hepatocytes.
    Madigan VJ; Tyson TO; Yuziuk JA; Pillai M; Moller-Tank S; Asokan A
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31391273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction.
    Nonnenmacher ME; Cintrat JC; Gillet D; Weber T
    J Virol; 2015 Feb; 89(3):1673-87. PubMed ID: 25410859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo tissue-tropism of adeno-associated viral vectors.
    Srivastava A
    Curr Opin Virol; 2016 Dec; 21():75-80. PubMed ID: 27596608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive biophysical characterization of AAV-AAVR interaction uncovers serotype- and pH-dependent interaction.
    Fu Y; Choudhary D; Liu N; Moon Y; Abdubek P; Sweezy L; Rosconi M; Palackal N; Pyles E
    J Pharm Biomed Anal; 2023 Sep; 234():115562. PubMed ID: 37441888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor Switching in Newly Evolved Adeno-associated Viruses.
    Havlik LP; Das A; Mietzsch M; Oh DK; Ark J; McKenna R; Agbandje-McKenna M; Asokan A
    J Virol; 2021 Sep; 95(19):e0058721. PubMed ID: 34232726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.
    Summerford C; Bartlett JS; Samulski RJ
    Nat Med; 1999 Jan; 5(1):78-82. PubMed ID: 9883843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway.
    Nonnenmacher M; Weber T
    Cell Host Microbe; 2011 Dec; 10(6):563-76. PubMed ID: 22177561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.
    Hüser D; Khalid D; Lutter T; Hammer EM; Weger S; Heßler M; Kalus U; Tauchmann Y; Hensel-Wiegel K; Lassner D; Heilbronn R
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.